Burnaby company granted Health Canada licence to produce 'magic mushroom' medicine
At Burnaby’s Albert Labs, it’s science meets nature. On the walls, you’ll find posters of various mushrooms next to scientific formulas, symbolizing the company's mission to develop mental health medicine derived from natural substances. The small team of around 20 employees recently received a Health Canada license to further pursue its work in producing psilocybin from mushrooms.
“Oh, it’s very big,” said Ali Gulamhusein, chief development officer for Albert Labs.
“That licence grants us the ability to produce, manufacture, export and import psilocybin.”
Gulamhusein refers to psilocybin as the magic medicine of the magic mushroom. The company also operates in the U.K. and Portugal, and plans to begin clinical trials in the U.K. this fall.
“(The) first early indications that we’re targeting is cancer-related anxiety,” said Gulamhusein, who adds that the company also hopes to treat people with depression, anxiety and PTSD.
Gulamhusein says the process involves isolating the psilocybin from the root and bio-engineering the drug in a controlled setting to help ensure consistency.
The company’s CEO says studies of the treatment have been overwhelmingly positive, calling psilocybin a potential game changer when it comes to mental illness therapy.
“One dose – and associated psychotherapy – cures anxiety for many months, and in some cases, permanently,” said Dr. Michael Raymont.
But it’s currently only available for Canadians with special permission from doctors. Christine Parlee lives with terminal stage four cancer and was granted permission for treatment to help ease her severe anxiety.
“It was phenomenal, probably one of the best experiences of my life to be honest,” said Parlee via Zoom from her home in Duncan.
“To say it changed me down to the bottom of my core is putting it mildly.”
One expert tells CTV News that despite high demand from patients, it could take two to three years before psychedelics become a common, more accessible treatment.
“I think there’s a lot of work to be done in training of professionals in understanding this new paradigm in mental health treatment,” said Dr. Devon Christie, senior lead of psychedelic programs at Numinus.
Meanwhile, if all goes well in the U.K., Albert Labs hopes to have its drug ready for trial in Canada by 2023.
CTVNews.ca Top Stories
'A beautiful soul': Funeral held for baby boy killed in wrong-way crash on Highway 401
A funeral was held on Wednesday for a three-month-old boy who died after being involved in a wrong-way crash on Highway 401 in Whitby last week.
Police handcuff man trying to enter Drake's Toronto mansion
Toronto police say a man was taken into custody outside Drake's Bridle Path mansion Wednesday afternoon after he tried to gain access to the residence.
Biden says he will stop sending bombs and artillery shells to Israel if they launch major invasion of Rafah
U.S. President Joe Biden said for the first time Wednesday he would halt shipments of American weapons to Israel, which he acknowledged have been used to kill civilians in Gaza, if Prime Minister Benjamin Netanyahu orders a major invasion of the city of Rafah.
U.S. presidential candidate RFK Jr. had a brain worm, has recovered, campaign says
Independent U.S. presidential candidate Robert F. Kennedy Jr. had a parasite in his brain more than a decade ago, but has fully recovered, his campaign said, after the New York Times reported about the ailment.
What is whooping cough and should Canadians be concerned as Europe declares outbreak?
There is currently a whooping cough epidemic in Europe, with 10 times as many cases compared to the previous two years. While an outbreak has not been declared nationwide in Canada, whooping cough is regularly detected in the country.
Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.
Quebec premier defends new museum on Quebecois nation after Indigenous criticism
Quebec Premier Francois Legault is defending his comments about a new history museum after he was accused by a prominent First Nations group of trying to erase their history.
B.C. theatre to pay $55K to neurodivergent actor in discrimination case
British Columbia's human rights tribunal has awarded a neurodigergent actor, who was diagnosed with sensory and learning disorders, more than $55,000 after finding that a Kelowna theatre company discriminated against him because of his disabilities.
Who's responsible for regulating cannabis stores operating under the sovereignty banner?
It's not quite clear who is supposed to be regulating so-called sovereign cannabis stores or even ensure they're benefiting Indigenous communities.